EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Nanoparticle ocular immunotherapy for herpesvirus surface eye infections evaluated in cat infection model

Michael Lappin, Kathryn Wotman, Lyndah Chow iD, Maggie Williams iD, Jennifer Hawley, Steven Dow iD

PLOS ONE · 06.01.2023 · 18 (1) · e0279462

DOI: 10.1371/journal.pone.0279462 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, online erschienen am 06.01.2023. Verfasst von Michael Lappin und 5 weiteren Autor:innen. Beteiligte Einrichtung: From the Translational Medicine Institute, Department of Clinical Sciences, College of Veterinary Medicine and Biomedical Sciences, Colorado State Un…. Hauptthemen laut MEDLINE: Keratitis, Herpesviridae Infections, Herpesviridae, Eye Infections, Viral. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Colorado State University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ocular herpes simplex type 1 (HSV-1) infections can trigger conjunctivitis, keratitis, uveitis, and occasionally retinitis, and is a major cause of blindness worldwide. The infections are lifelong and can often recrudesce during periods of stress or immune suppression. Currently HSV-1 infections of the eye are managed primarily with anti-viral eye drops, which require frequent administration, can cause irritation, and may take weeks for full resolution of symptoms. We therefore evaluated the effectiveness of an ocular immune activating nanoparticle eye drop as a novel approach to treating HSV-1 infection, using a cat feline herpesvirus -1 (FHV-1) ocular infection model. In vitro studies demonstrated significant induction of both type I and II interferon responses by the liposome-dual TLR 3/9 agonist nanoparticles, along with suppression of FHV-1 replication. In cats with naturally occurring eye infections either proven or suspected to involve FHV-1, ocular nanoparticle treated animals experienced resolution of signs within several days of treatment, including resolution of keratitis and corneal ulcers. In a cat model of recrudescent FHV-1 infection, cats treated twice daily with immune nanoparticle eye drops experienced significant lessening of ocular signs of infection and significantly fewer episodes of viral shedding compared to control cats. Treatment was well-tolerated by all cats, without signs of drug-induced ocular irritation. We concluded therefore that non-specific ocular immunotherapy offers significant promise as a novel approach to treatment of HSV-1 and FHV-1 ocular infections.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

KeratitisHerpesviridae InfectionsHerpesviridaeEye Infections, ViralCat DiseasesImmunotherapyVaricellovirusOphthalmic SolutionsCatsAnimals

Substanzen

Ophthalmic Solutions

Autor:innen und Institutionen

  • From the Translational Medicine Institute, Department of Clinical Sciences, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins, Colorado, United States of America.

ORCID-Profile: Lyndah Chow, Maggie Williams, Steven Dow

Förderung

  • Colorado State University

Zitieren

APA

Lappin, M., Wotman, K., Chow, L., Williams, M., Hawley, J., & Dow, S. (2023). Nanoparticle ocular immunotherapy for herpesvirus surface eye infections evaluated in cat infection model. PLOS ONE, 18(1), e0279462. https://doi.org/10.1371/journal.pone.0279462

Vancouver

Lappin M, Wotman K, Chow L, Williams M, Hawley J, Dow S. Nanoparticle ocular immunotherapy for herpesvirus surface eye infections evaluated in cat infection model. PLOS ONE. 2023;18(1):e0279462. doi:10.1371/journal.pone.0279462

BibTeX
@article{Lappin2023,
  author = {Lappin, Michael and Wotman, Kathryn and Chow, Lyndah and Williams, Maggie and Hawley, Jennifer and Dow, Steven},
  title = {Nanoparticle ocular immunotherapy for herpesvirus surface eye infections evaluated in cat infection model},
  journal = {PLOS ONE},
  year = {2023},
  volume = {18},
  number = {1},
  pages = {e0279462},
  doi = {10.1371/journal.pone.0279462}
}
Kostenlos starten →